中等度から重度のアトピー性皮膚炎患者における抗OX40モノクローナル抗体（KHK4083）の研究
基本情報
- NCT ID
- NCT03703102
- ステータス
- 完了
- 試験のフェーズ
- 第2相
- 試験タイプ
- 介入
- 目標被験者数
- 274
- 治験依頼者名
- Kyowa Kirin Co., Ltd.
概要
A Phase 2, multicenter, randomized, placebo-controlled, double-blind, parallel-group study for subjects with moderate to severe AD whose disease cannot be adequately controlled with topical medications or for whom topical treatment is medically inadvisable.
対象疾患
介入
実施施設 (31)
Kyowa Investigational Site JP-18
Mie, Japan
Kyowa Investigational Site JP-25
Shimane, Japan
Kyowa Investigational Site JP-07
Tokyo, Japan
Kyowa Investigational Site JP-10
Kagoshima, Japan
Kyowa Investigational Site JP-28
Morioka, Japan
Kyowa Investigational Site JP-16
Tokyo, Japan
Kyowa Investigational Site JP-13
Tokyo, Japan
Kyowa Investigational Site JP-04
Hokkaido, Japan
Kyowa Investigational Site JP-23
Tokyo, Japan
Kyowa Investigational Site JP-26
Fukuoka, Japan
Kyowa Investigational Site JP-01
Hokkaido, Japan
Kyowa Investigational Site JP-11
Kagoshima, Japan
Kyowa Investigational Site JP-17
Aichi, Japan
Kyowa Investigational Site JP-22
Tokyo, Japan
Kyowa Investigational Site JP-21
Kanagawa, Japan
Kyowa Investigational Site JP-12
Fukuoka, Japan
Kyowa Investigational Site JP-29
Hokkaido, Japan
Kyowa Investigational Site JP-03
Tokyo, Japan
Kyowa Investigational Site JP-08
Fukuoka, Japan
Kyowa Investigational Site JP-09
Fukuoka, Japan
Kyowa Investigational Site JP-15
Tochigi, Japan
Kyowa Investigational Site JP-20
Miyagi, Japan
Kyowa Investigational Site JP-06
Kanagawa, Japan
Kyowa Investigational Site JP-02
Hokkaido, Japan
Kyowa Investigational Site JP-19
Fukuoka, Japan
Kyowa Investigational Site JP-30
Tokyo, Japan
Kyowa Investigational Site JP-14
Gifu, Japan
Kyowa Investigational Site JP-31
Ibaraki, Japan
Kyowa Investigational Site JP-27
Aichi, Japan
Kyowa Investigational Site JP-24
Chiba, Japan
Kyowa Investigational Site JP-05
Kanagawa, Japan